George Sellers
Stock Analyst at Stephens & Co.
(1.08)
# 3,843
Out of 5,157 analysts
45
Total ratings
28.57%
Success rate
-6.86%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Maintains: Overweight | $85 → $90 | $69.06 | +30.32% | 8 | Feb 25, 2026 | |
| GKOS Glaukos | Maintains: Overweight | $115 → $145 | $105.78 | +37.08% | 5 | Jan 2, 2026 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $113.61 | +155.26% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $34.12 | +69.99% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $134.77 | +32.08% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $14.96 | +60.43% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $24.66 | +191.97% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $3.43 | +45.77% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $1.65 | +1,415.15% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $18.32 | +211.14% | 6 | Aug 14, 2023 |
Establishment Labs Holdings
Feb 25, 2026
Maintains: Overweight
Price Target: $85 → $90
Current: $69.06
Upside: +30.32%
Glaukos
Jan 2, 2026
Maintains: Overweight
Price Target: $115 → $145
Current: $105.78
Upside: +37.08%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $113.61
Upside: +155.26%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $34.12
Upside: +69.99%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $134.77
Upside: +32.08%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $14.96
Upside: +60.43%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $24.66
Upside: +191.97%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $3.43
Upside: +45.77%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $1.65
Upside: +1,415.15%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $18.32
Upside: +211.14%